JCP Weekly

depression

Clinical and Practical Psychopharmacology

Gestational Exposure to Benzodiazepines, 2: The Risk of Congenital Malformations Examined Through the Prism of Compatibility Intervals

J Clin Psychiatry 2019;80(5):19f13081

Clinical and Practical Psychopharmacology

Gestational Exposure to Benzodiazepines, 1: The Risk of Spontaneous Abortion Examined Through the Prism of Research Design

J Clin Psychiatry 2019;80(5):19f13076

Clinical and Practical Psychopharmacology

Anticholinergic Drug Exposure and the Risk of Dementia: There Is Modest Evidence for an Association but Not for Causality

J Clin Psychiatry 2019;80(4):19f13000

Clinical and Practical Psychopharmacology

Antidepressant Drugs and the Risk of Hip Fracture in the Elderly: Is There More to It Than Confounding by Indication?

J Clin Psychiatry 2019;80(4):19f12999

Clinical and Practical Psychopharmacology

Intellectual Disability After Gestational Exposure to Antidepressant Drugs: The Confidence Interval as a Compatibility Interval

J Clin Psychiatry 2019;80(3):19f12912

Clinical and Practical Psychopharmacology

Anti-Inflammatory Treatments for Depression: Perspectives on How to Read a Meta-Analysis Critically

J Clin Psychiatry 2019;80(3):19f12907

Clinical and Practical Psychopharmacology

Oral Ketamine for Depression, 2: Practical Considerations

J Clin Psychiatry 2019;80(2):19f12838

Clinical and Practical Psychopharmacology

Oral Ketamine for Depression, 1: Pharmacologic Considerations and Clinical Evidence

J Clin Psychiatry 2019;80(2):19f12820

Clinical and Practical Psychopharmacology

Antidepressants, Mood Stabilizers, Antipsychotics, and the Risk of Cataract

J Clin Psychiatry 2019;80(1):19f12744

Clinical and Practical Psychopharmacology

Antidepressants and Atrial Fibrillation: The Importance of Resourceful Statistical Approaches to Address Confounding by Indication

J Clin Psychiatry 2019;80(1):19f12729

1 - 10 Next